Candidate biomarkers in heart failure with reduced and preserved ejection fraction.
Patients presenting with heart failure symptoms are categorized into heart failure (HF) with reduced and preserved ejection fraction. Aim is to investigate the additional use of candidate biomarkers to characterize patients with either sub-type of HF. Literature search was conducted in the electronic databases MEDLINE and Cochrane Central Register of Controlled Trials from inception through November 2014. The results of 47 diseased and general population cohorts were included. Current studies could outline the additional use of candidate biomarkers especially GDF-15, MR-proADM and high-sensitive determined troponin, although major outcome studies are still missing.